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A B S T R A C T
The rising epidemic of non-communicable diseases (NCDs) poses substantial health and economic challenges to
both individuals and society. Application of incentive-based strategies based on traditional and behavioural
economic theory has emerged as a potential strategy to address rising rates of NCDs. Yet, whether or not in-
centives truly represent a promising strategy for addressing NCDs has not been systematically addressed nor is it
clear whether certain behavioural economic strategies outperform others or simply oﬀering a cash-based in-
centive for meeting a goal. In this systematic review we aim to determine whether there is an evidence base for
any of these strategies. Forty-eight published randomized controlled trials (70 contrasts) evaluating the eﬀec-
tiveness of incentive-based strategies for improvements in NCD risk-factors were reviewed. Our primary con-
clusion is that there is a lack of compelling evidence that incentives of any form represent a compelling NCD
reduction strategy. More evidence for long-term eﬀectiveness and cost-eﬀectiveness is needed to justify third
party funding of any incentive based strategy.
1. Introduction
Non-communicable diseases (NCDs) pose substantial health and
economic challenges both at the individual and societal levels. NCDs
account for an estimated 38 million deaths annually, of which 16 mil-
lion are premature death (World Health Organization, 2015). Re-
cognizing this as an “invisible epidemic”, the World Health Organisa-
tion seeks to reduce premature deaths from NCDs by one-third by 2030
(World Health Organization, 2017).
NCD prevention eﬀorts focus primarily on four modiﬁable beha-
vioural risk factors - physical inactivity, unhealthy diet, and the harmful
use of alcohol and tobacco (World Health Organization, 2015). These
four risk factors promote four key metabolic/physiological changes
(raised blood glucose, blood pressure, cholesterol and obesity) that in
turn increase risks for at least four NCDs, including cardiovascular
diseases, cancers, respiratory diseases, and diabetes. Given the in-
creasing prevalence of NCDs across all age groups and a dispropor-
tionate burden on low and middle-income countries, there is a pressing
need for low cost, cost-eﬀective, and scalable NCD prevention strate-
gies.
The use of (dis)incentives to encourage healthy behaviours, either
alone or as part of a multi-component intervention, is one strategy
under consideration in both lower and higher income settings (Gaarder
et al., 2010; Health Promotion Board (Singapore), 2014; Lagarde et al.,
2007, 2009; Ranganathan and Lagarde, 2012; USDA, 2018). These
could take the form of monetary or non-monetary rewards or penalties
for meeting a pre-deﬁned process or outcome measure, such as at-
tending a ﬁtness session or losing weight, or less frequently, a penalty if
the goal is not met. Why should we expect incentive-based strategies to
work? Classical economic theory assumes that individuals are rational,
forward-looking and weigh the costs and beneﬁts of their decisions. If
an individual is given a reward (penalty) for engaging in a healthy
(unhealthy) behaviour, the theory predicts she will be more (less) likely
to do it. Theory also predicts that, ceteris paribus, incentives are more
likely to be eﬀective among lower-income populations both because
they are likely to have a lower opportunity cost of their time and be-
cause the value of the reward represents a larger percentage increase in
disposable income available to the participant (Sutherland et al., 2008).
However, if an intervention already includes several eﬀective compo-
nents, then the opportunity cost of even greater changes in behaviour
will be that much more diﬃcult, and therefore, we would expect the
marginal beneﬁt of incentives to be smaller, all else equal.
Behavioural economists and psychologists recognize that not ev-
eryone is rational and many individuals may not perceive a clear cause-
and-eﬀect relationship between healthy behaviours and their decreased
likelihood of developing a NCD, which may not occur until well into the
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future (Chapman et al., 2001). Incentives address this problem by
providing individuals with a short-term reward for health behaviours.
These researchers oﬀer additional insights into when incentives may –
or may not – work as intended. In doing so, the theory points to several
aspects of intervention design that could inﬂuence their short and long-
term cost-eﬀectiveness. These include design features concerning the
size, type, frequency, and duration of incentive payments. The theory
also warns us to “pay enough or don't pay at all” (Gneezy and
Rustichini, 2000) based on the idea that incentives that are too small
may confer a signal of low value and be worse than oﬀering no in-
centive at all.
Many incentive-based interventions include a lottery component.
However, because individuals are risk averse (Kahneman and Tversky,
1979), a guaranteed reward should be more eﬀective at inﬂuencing
behaviour than a lottery with the same expected value. However, if two
lotteries of equal expected value are oﬀered, prospect theory posits that
the lottery with the lower probability but a larger pay-out will be more
eﬀective, because people overweight small probabilities and under-
weight moderate and large probabilities.
The type of incentive may also matter. Classical economists argue
that cash is best because it is the most fungible. However, non-cash
incentives have been posited to be more eﬀective than cash if they are
earmarked to pleasurable (hedonic) rewards (Jeﬀrey, 2009; Jeﬀrey and
Shaﬀer, 2007; Kelly et al., 2015; R. Thaler, 1985; R. H. Thaler, 1999).
Loss aversion predicts that individuals prefer avoiding losses to ac-
quiring equivalent gains, suggesting that deposit contracts should be
more eﬀective than rewards of equal value. How often incentives are
paid and the duration of rewards programs are two additional con-
siderations. Hyperbolic discounting suggests that individuals discount
the future to a larger extent in the short term than in the longer term
(Read and Van Leeuwen, 1998; R. Thaler, 1981). Therefore frequent
rewards that focus on short-term behaviours or outcomes may be ef-
fective at encouraging individuals to overcome the temptation to en-
gage in present-biased behaviour.
NCD prevention ultimately requires forming a habit of healthy be-
haviours. Classical economic theory suggests that individuals who make
a behaviour change due to the prospect of rewards will be less likely to
engage in the behaviour once it is no longer incentivised. Contrarily,
the psychological theory of operant conditioning suggests that modiﬁed
behaviours can be sustained by repeatedly associating a reward (or
punishment) with that behaviour (Skinner, 1963). This idea is echoed
in more recent research suggesting that creating a loop of “cue-routine-
reward” can lead to habit formation (Duhigg, 2012). The habit forma-
tion literature suggests that interventions with longer durations, with
24 weeks as an oft-cited time frame (Mantzari et al., 2015; Volpp et al.,
2009), are more likely to produce lasting eﬀects (Lally et al., 2008; Lally
and Gardner, 2013; Neal et al., 2006; Ouellette and Wood, 1998; Wood
et al., 2005).
The above-mentioned aspects of incentive design have the potential
to inﬂuence their eﬀectiveness, costs, and cost-eﬀectiveness. Although
many review articles and meta-analyses have focused on the eﬀec-
tiveness of incentives and their ability to inﬂuence health behaviours,
to date only two studies, both meta-analyses, have attempted to address
the relative eﬀectiveness of diﬀerent types of incentive features tar-
geting multiple risk factors for NCDs (Giles et al., 2014; Mantzari et al.,
2015). These studies addressed reward size (Giles et al., 2014; Mantzari
et al., 2015), certainty vs. lottery rewards (Mantzari et al., 2015),
participant deprivation levels (in terms of their income, employment or
socio-economic status) (Mantzari et al., 2015) and length of post-in-
tervention follow-up (Giles et al., 2014).
As with other studies that focus on single risk factors for NCDs, both
reviews conclude that incentives work to positively inﬂuence health
behaviours. However, in contrast to classical economic theory, both
studies ﬁnd that larger rewards only work better in the case of smoking
cessation. Mantzari et al. (2015) ﬁnds no evidence that lottery pay-
ments are inferior to cash but oﬀers some evidence that incentive
eﬀects are greater among more deprived participants (only at > 6–12
months from baseline). Concerning habit formation, Mantzari et al.
(2015) notes that incentive eﬀects are sustained for up to 3 months
post-incentive removal and Giles et al. (2014) ﬁnd that eﬀect sizes
decrease with post-intervention follow-up duration.
Although the prior meta-analyses (Giles et al., 2014; Mantzari et al.,
2015) oﬀer some insights, a careful look at the incentive design across
the included studies shows signiﬁcant heterogeneity in many factors,
including how the dependent variable is measured, the target popula-
tion, whether the incentive strategy is used alone or in conjunction with
other intervention features, in addition to the size, frequency, duration,
and type of reward oﬀered. To account for these diﬀerences, the au-
thors made several simplifying assumptions in some cases (e.g.,
Mantzari et al. (2015) classiﬁed rewards as high vs low using a single
threshold value that is independent of duration) or completely ignored
diﬀerences in others, such as frequency of reward payments. As a result,
their results may suﬀer from both a lack of statistical power and sys-
tematic bias (e.g., studies with higher reward values also had longer
durations). Moreover, the reviews do not answer the primary question
posed here, which is whether or not an investment in any of the above
strategies would represent a good use of scarce resources as a means for
addressing rising rates of NCDs.
The purpose of this systematic review is to revisit and synthesize the
evidence of eﬀectiveness and cost-eﬀectiveness of incentives speciﬁ-
cally as a tool for NCD prevention. Rather than attempting to meta-
analyse the results across very heterogeneous studies, we provide an
updated and more comprehensive synthesis of components of inter-
vention design aspects that could potentially inﬂuence the eﬀectiveness
of incentive strategies based on classical and behavioural economic/
psychology theory. In doing so, we also consider a wider evidence base
for the eﬀectiveness of economic incentives by (1) placing no restric-
tions on the type of economic incentive oﬀered (Giles et al., 2014) and
(2) including studies that incentivise weight loss given its link to diet,
physical activity, and NCDs and the fact that it is a common target for
incentives. Unlike prior reviews, we also consider how the frequency of
rewards could inﬂuence their eﬀectiveness and whether use of in-
centives may be cost-eﬀective for prevention and treatment of NCDs.
This is critical as evidence of cost-eﬀectiveness would strengthen the
argument for subvention of incentive-based programs.
Speciﬁcally, we provide a detailed synthesis of the evidence for
eﬀectiveness and cost-eﬀectiveness of incentives for healthy eating,
physical activity, weight loss, smoking cessation and alcohol con-
sumption overall and with respect to the following aspects of inter-
vention design:
i. Target population and setting,
ii. Independent strategy or part of a multicomponent intervention,
iii. Incentive type,
iv. Incentive size,
v. Frequency of opportunity to earn incentives,
vi. Intervention duration, and
vii. Evidence for habit formation among eﬀective studies.
To keep the review tractable and minimize potential sources of bias,
we limited it to randomized controlled trials with a measured primary
endpoint. We also conduct a quality assessment for all included studies
in eﬀorts to identify potential biases and to understand why results may
or may not be consistent with the theory. Based on the results of the
review we conclude with a summary of the evidence as it pertains to
NCD risk reduction and provide recommendations for future research.
2. Methods
This review was conducted in line with PRISMA guidelines for
systematic reviews (Moher et al., 2009). The protocol for the review
was registered on PROSPERO (CRD42018100638).
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2.1. Data sources and search strategy
Two reviewers searched for all English-language published articles
from January 1995 until June 2018 across the following four databases:
PUBMED (accessed via National Centre for Biotechnology Information),
PsycINFO (accessed via OvidSP), EconLit (accessed via Ovid) and
EMBASE (accessed via Elsevier). Databases were searched using terms
identiﬁed from title, abstract, keywords or medical subject headings.
The search took the general form of ([incentive type] AND [target be-
haviour]). For example, the search used for physical activity is de-
scribed here:
(‘ﬁnancial incentive*’ OR ‘incentive*’ OR ‘economic incentive*’ OR
‘monetary incentive*’ OR ‘cash’ OR ‘lotter*’ OR ‘lotto*’ OR ‘deposit*’
OR ‘deposit contract*’ OR ‘voucher*’ OR ‘ticket*’ OR ‘bonus program*’
OR ‘bonus*’ OR ‘cheque*’ OR ‘notes*’ OR ‘monetary beneﬁt*’ OR ‘cash
beneﬁt*’ OR ‘ﬁnancial beneﬁt*’ OR ‘reward*’ OR ‘ﬁnancial reward*’ OR
‘monetary reward*’ OR ‘cash reward*’ OR ‘prize*’ OR ‘cash prize*’ OR
‘money’ OR ‘non-cash reward*’) AND (‘physical activ*’ OR ‘physical
inactiv*’ OR ‘insuﬃcient physical activ*’ OR ‘movement*’ OR ‘bodily
movement*’ OR ‘exercise*’ OR ‘exercise behavio*r’ OR ‘physical
training*’ OR ‘training*’ OR ‘ﬁtness’ OR ‘sport*’ OR ‘walk*’ OR ‘gym’
OR ‘motor activ*’ OR ‘physical exercise*’ OR ‘acute exercise*’ OR
‘aerobic exercise*’ OR ‘exercise training*’ OR ‘run*’)
The search terms and MeSH terms used were adapted for the in-
dividual databases need. The full search strategy for each target beha-
viour can be found in Appendix Table 1.
2.2. Study selection
We included all randomized control trials lasting at least four weeks
if they comprised economic incentives tied to one of the following: (i)
increased physical activity; (ii) weight loss; (iii) smoking cessation; (iv)
positive changes in dietary behaviour (in terms of increased fruit and
vegetable consumption, reduced consumption/purchase of sugar
sweetened beverages, and/or increased consumption/purchase of low-
calorie food items) and (iv) reduced alcohol consumption/purchases.
Studies were included if the primary outcome was the eﬀectiveness of
the incentive-based intervention (in terms of the incentivised beha-
viour/goal) oﬀered relative to the control group. For studies in which a
primary outcome was not reported (n=11), we ﬁrst considered the
measure of eﬀectiveness that is most commonly reported among studies
in the same health domain, then the measure directly tied to the in-
centive, or, if necessary, the ﬁrst measure reported when incentives
were tied to multiple outcomes. Within included studies, we only in-
cluded comparisons between arms (referred to as contrasts henceforth)
in which the independent eﬀect of incentives could be inferred relative
to another intervention arm.
Studies were excluded if the primary outcome was based on self-
report as those in the intervention arm have an incentive to mis-
represent their behaviour, if the eﬀect of incentives was confounded
with other aspects of the intervention, and/or where incentives were
tied to group behaviour. We further excluded studies if the incentives
were oﬀered to healthcare providers to change patient behaviour, tar-
geted children, or focussed exclusively on those with mental-health
and/or substance abuse conditions.
2.3. Data extraction
The initial search identiﬁed 58,367 records, and 42,342 were sub-
ject to title/abstract screening after duplicates were removed. Screening
was conducted by two independent reviewers (YG and DB). 83 articles
were identiﬁed as eligible for full-text review (Fig. 1 – PRISMA ﬂow-
chart). Full text screening was performed by two independent reviewers
and conﬂicts were resolved by consensus. Reference lists of included
articles were also checked for any articles that were potentially missed
from the search, but no unique articles were identiﬁed. In total, 48
articles met the inclusion criteria and were included in the study.
Data was extracted using a pre-designed and pre-tested data ex-
traction template to extract the following information from each study:
(1) publication details – author, date of publication; (2) study design –
inclusion and exclusion criteria, sample size, description of intervention
received by treatment and control group; (3) intervention character-
istics – type of incentive, incentive size, frequency of incentive pay-
ment, duration of intervention, evidence for habit formation, cost and
cost-eﬀectiveness of intervention; and (4) eﬀectiveness of intervention –
primary outcome of the study. Incentive size was calculated as the
maximum incentive the participant could expect to receive if she
met all opportunities to earn incentives over the duration of the inter-
vention. For lotteries, maximum pay-out was calculated as the expected
value. For non-cash rewards the value of the reward in monetary terms
was considered. All monetary ﬁgures were converted to Purchasing
Power Parity dollars (World Bank, 2017) for 2017 using country spe-
ciﬁc inﬂation rates (International Monetary Fund, 2017). Duration of
the intervention was deﬁned as the time period between the start of the
intervention and the ﬁnal opportunity to earn an incentive. The data
extracted from all studies included in the review are summarised in
Appendix Table 2.
2.4. Critical appraisal
Risk of bias assessment was conducted for all articles that met the
inclusion criteria using the Cochrane Risk of Bias Assessment tool. This
tool, speciﬁcally designed for clinical trials, evaluates the methodolo-
gical quality of studies using the following six criteria: selection bias,
performance bias, detection bias, attrition bias, reporting bias, and
other biases. Risk of bias assessment was performed by one reviewer
(YG) and cross-checked by another (DB). All review team members
(EAF and MB) were consulted in case of ambiguities/conﬂicts.
Diﬀerences were resolved by discussion. Regardless of risk of bias, all
studies reviewed are included in the narrative synthesis, with im-
plications for low quality studies addressed in the Discussion section.
2.5. Outcome measures and data analysis
For all contrasts considered, we tabulated whether the incentive-
based intervention was eﬀective or not based on whether the study
reported statistically signiﬁcant diﬀerences between the incentive and
no-incentive arm on the primary outcome and the direction of the ef-
fect, if signiﬁcant. For studies with multiple incentive arms we con-
sidered all contrasts that met our inclusion criteria.
3. Results
A total of 48 full-text articles were reviewed. Among these articles,
70 contrasts allowed for identifying the independent eﬀect of incentives
relative to a no-incentive arm. Studies/contrasts reviewed are sum-
marised in Table 1. By health domain: 3 contrasts tied incentives to
healthy food purchases; 18 to weight loss; 11 to physical activity; 12 to
ﬁtness session attendance; 24 to smoking cessation, and none to al-
cohol. Two contrasts tied incentives to both weight loss and physical
activity goals (Finkelstein et al., 2017; Shin et al., 2017). In 6 studies,
incentives were tied to other aspects of a multicomponent intervention
(e.g., participation in smoking cessation programs, use of a weight loss
website, etc.) in addition to the target behaviour. This review features a
small number of studies focussing on diet and a lack of alcohol studies
due to exclusion of studies that relied on self-report and studies that
focused solely on populations with mental health and/or substance
abuse conditions due to concerns about generalizability.
Below we present characteristics of the included studies, including
variation in key intervention design aspects likely to inﬂuence inter-
vention eﬀectiveness. We then present overall and domain-speciﬁc ef-
fectiveness results and evidence for how eﬀectiveness varies by
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population, comparator group, value, type, frequency, and duration of
incentives, followed by the evidence for habit formation and cost-ef-
fectiveness. Lastly, we present a risk of bias assessment for the primary
outcome of all included studies.
3.1. Characteristics of included studies
3.1.1. Population and setting
The vast majority of studies focused on adult populations in high
income countries (68 contrasts), and primarily the US (60 contrasts).
Twenty-ﬁve of 70 contrasts were evaluated in a community setting
(36%), 27 in a workplace environment (39%), 14 focused on out-
patients of a medical centre (20%) and 4 in a ﬁtness centre (6%). Within
each health domain, the target population diﬀered. All weight loss in-
terventions and 3 interventions incentivising ﬁtness centre attendance
or physical activity targeted an overweight and/or obese population. A
third of contrasts (8 of 24, (33%)) that tied incentives to smoking
cessation speciﬁcally targeted pregnant women, a highly motivated
subset of smokers. Across all domains, only 6 contrasts speciﬁed that
their intervention exclusively targeted low-income populations either
as part of their inclusion criteria or description of the sample.
3.1.2. Comparator group
For the majority of contrasts (41 contrasts (58%)), the incentive was
given as part of a multi-component intervention. In these contrasts, the
incremental eﬀect of the incentive was measured relative to a control
group that received an intervention without the incentive. For instance,
over half of weight loss studies combined incentives with other evi-
dence-based weight loss strategies, including face to face counselling (8
of 20 contrasts, (40%)) or goal-setting (5 of 20 contrasts, (25%))
(Finkelstein et al., 2017; John et al., 2011; Jeﬀrey T Kullgren et al.,
2016; Paloyo et al., 2015; N. M. Petry et al., 2011; Volpp et al., 2008).
Two-thirds (16 out of 24 contrasts) of smoking cessation interventions
combined incentives with cessation programs including counselling,
personalised feedback or cognitive behavioural therapy (11 contrasts)
and/or other cessation resources such as nicotine gum, computerized
cessation interventions, or social support for cessation (5 contrasts).
Two of the 3 diet contrasts combined incentives with a food-assistance
program, and the third combined incentives with a social-norm based
feedback intervention.
Among the remaining 29 contrasts (41%), 10 contrasts focused so-
lely on incentives compared to a control group that received no inter-
vention and 19 had minimal interventions that were unlikely to more
than minimally aﬀect the target behaviour. Minimal interventions in-
cluded provision of information about ﬁtness programs/smoking
Fig. 1. Prisma ﬂow diagram.
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cessation programs (6 contrasts), tips on how to quit smoking or ex-
ercise more and/or general ﬁtness/weight loss goals (2 contrasts),
pedometers with or without daily/weekly feedback on whether step-
goals were met (5 contrasts), access to weighing scales with en-
couragement to weigh themselves as often as they like (3 contrasts),
abstinence monitoring for smokers (1 contrast) and free access to a
behavioural smoking cessation program (1 contrast).
3.1.3. Outcome measure
Even within health domains, the primary measure of eﬀectiveness
diﬀered, especially among the physical activity domain. In this domain,
interventions reported proportion of ﬁtness sessions attended (4 con-
trasts), proportion of days a step-goal was met (5 contrasts), proportion
of participant-days a step-goal was met (4 contrasts), number of visits
or average weekly gym visits attended (7 contrasts), whether a target
number of ﬁtness centre visits was reached (1 contrasts) or active
minutes (2 contrasts). Majority of smoking cessation interventions used
a biochemically veriﬁed 7 day point-prevalence abstinence rate (ver-
iﬁed by either saliva/urine cotinine/breath CO tests) as the primary
endpoint (13 contrasts). The primary outcome was sustained abstinence
in two studies, wherein participants had to be biochemically conﬁrmed
abstinent at more than one time point to be considered abstinent (3
contrasts). Three studies used a biochemical veriﬁcation of cessation
(urine cotinine/breath CO) without a point prevalence abstinence
measure. Other measures used were 24-h abstention rates (2 contrasts),
percent of negative CO samples (3 contrasts). Among the diet inter-
ventions, mean expenditure on fruit in dollars (2 contrasts) or propor-
tion of healthy food purchases (1 contrast) was used. Outcomes were
most consistent in weight loss studies, where mean weight loss was used
in all but two contrasts that instead focused on the proportion of par-
ticipants achieving>5% weight loss (N. M. Petry et al., 2011) or the
percentage weight loss relative to baseline (Leahey et al., 2015).
3.1.4. Duration
Length of interventions varied from 4 to 78 weeks. Median duration
across all studies was 16 weeks and was largest in the smoking domain
(median: 24 weeks). Only a third of contrasts (29 of 70, (41%) lasted 24
weeks or longer, the duration that has been reported necessary for a
habit to accrue. Ten of these incentivised weight loss, 1 incentivised
physical activity, 1 incentivised both weight loss and physical activity,
3 incentivised ﬁtness session attendance and 14 incentivised smoking
cessation. Among contrasts that incentivised smoking cessation, almost
half (6 of 14, (43%)) had an intervention period of 24 weeks or greater
as they incentivised smoking cessation among pregnant smokers until/
post-birth. Few contrasts (7 of 70, (10%)) lasted 52 weeks or greater.
Among these, 2 contrasts incentivised ﬁtness session attendance, 2 in-
centivised smoking cessation and 3 contrasts incentivised weight loss.
3.1.5. Incentive type
The incentives oﬀered can be broadly classiﬁed into ﬁve types: cash
(23 contrasts, (33%)), lotteries (8 contrasts (11%)), deposit contracts (8
contrasts (11%)), non-cash incentives (19 contrasts (27%)) and a
combination (12 contrasts (17%)). Two studies (2 contrasts) gave par-
ticipants an option between a cash incentive and a cash plus deposit
contract incentive or a cash incentive and a cash plus lottery incentive.
Four studies (5 contrasts) used a lottery tied to non-cash prizes. Four
studies (5 contrasts) combined cash incentives along with additional
incentives (lottery, non-cash, or a deposit contract incentive).
In most interventions oﬀering deposit contract incentives as the
only incentive, the voluntary deposit was combined with a matching
incentive (5 of 8 (63%)). This was done in eﬀorts to increase the
amount of money participants put at risk to increase intervention ef-
fectiveness, and was most common in the weight loss domain. This
enabled participants to earn a 100% return (3 contrasts), a 100% return
and a ﬁxed return per day (1 contrast) or a 200% return (1 contrast) on
the amount deposited by the participant.
Various types of non-cash incentives were oﬀered either as an in-
dependent incentive strategy or as part of a bundle of incentives across
studies. Thirteen contrasts used vouchers for retail items or gift cards, 3
contrasts used ﬁtness centre memberships, 2 contrasts used rebates that
could be used for groceries and 2 contrasts used adjustments in health
insurance premiums and 4 contrasts used a range of “small” (eg.
Toiletries, water bottles, food, etc) and “large” (ﬁtness equipment, DVD
players, etc.) non-cash incentives in a lottery. In one study (1 contrast),
participants selected an item from an online retail store at the start of
the intervention that they would later receive as an incentive if they
met their ﬁtness goals. In one study, a voucher incentive was used but
the rewards that could be claimed for the voucher was not reported.
Among interventions including non-cash incentives, 17 of 26 contrasts
(65%) were more likely to be perceived as hedonic (gift cards, retail
items, ﬁtness centre memberships etc.) as compared to the 9 other
contrasts which were either tied to utilitarian items (6 contrasts) (such
as grocery vouchers, adjustments in health insurance premiums, etc.) or
were cash-like in that they could be exchanged for a large range of
rewards (3 contrasts) that may or may not be perceived as hedonic.
3.1.6. Frequency of opportunities to earn incentives
Most contrasts (56 of 70, (80%)) oﬀered multiple opportunities to
earn incentives. Many oﬀered daily incentives (17 contrasts), on al-
ternate days (1 contrast), thrice weekly (4 contrasts), weekly (11 con-
trasts), while others oﬀered monthly incentives (3 contrasts). Frequent
chances to earn incentives were most common among physical activity
interventions (11 of 11 contrasts) where incentives were tied to daily/
weekly step-goals. Among other domains, frequent chances to earn
incentives were based on interim weight loss goals on a daily/weekly
basis (13 contrasts), attendance at daily/weekly ﬁtness sessions (4
contrasts), meeting weekly physical activity minute goals (1 contrast),
weekly/monthly food purchases (3 contrasts), participating in smoking
cessation program sessions (4 contrasts) or veriﬁed abstinence at mul-
tiple points during the intervention (15 contrasts). The longest period in
which an incentive could be earned was 6 months, for smoking ab-
stinence.
Among 20 contrasts, variable incentive schedules were used instead
of oﬀering incentives at a regular frequency. The vast majority of these
were smoking cessation interventions (16 of 20 contrasts (80%)).
Almost two-thirds (13 contrasts) of these oﬀered more frequent chances
to earn incentives in the initial stages of the intervention to encourage
initial behaviour change. Among the remaining 7 contrasts, a variable
payment resulted from the fact that incentives were tied to participa-
tion/completion of other intervention components in addition to a
targeted risk-factor reduction (4 contrasts), depended on participants to
self-report meeting a target and claim their reward (2 contrasts). In one
contrast incentives were only oﬀered toward the end of the interven-
tion.
3.1.7. Incentive size
Maximum potential incentive pay-outs ranged from $29–1736
across all studies, with a median value of $360. The largest potential
pay-outs were in the weight loss and smoking domains, with maximum
potential pay-outs ranging from $47 to 1544 (median: $556) and
$155–1736 (median: $402) respectively. Maximum potential pay-outs
for the other domains are as follows: diet (range: $31–136, median:
$136), ﬁtness session attendance (range: $29–738, median: $108) and
physical activity (range: $114–853; median: $320). These pay-outs are
highly inﬂuenced by the intervention duration. The median maximum
potential pay-out was $293 for interventions that lasted 24 weeks or
less, and $738 for longer interventions.
3.2. Evidence for the eﬀectiveness of interventions
In total, over two-thirds of contrasts (48 of 70, (69%)) reported
statistically signiﬁcant evidence that the use of incentives improved the
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targeted risk factors. Thirteen contrasts (13 of 20, (65%)) were eﬀective
for weight loss, 5 contrasts (5 of 11, (45%)) for physical activity, 10 (10
of 12, (83%)) contrasts for ﬁtness session attendance, 1 contrast (1 of 3,
(33%)) for healthy food purchases, and 19 contrasts (19 of 24, (79%))
for smoking cessation. Considering the subset of studies (8 contrasts) in
which incentives were tied to multiple targets, either tied to multiple
risk-factors or tied to program participation/completion in addition to
risk-factor reductions, all but one were eﬀective (7 of 8 contrasts
(88%)).
3.2.1. Eﬀectiveness according to comparators
Among interventions in which incentives were used as part of a
multi-component strategy, 29 out of 41 (71%) were eﬀective. Among
interventions where incentives were used as a standalone strategy or
coupled with minimal interventions 17 out of 29 (58%) were eﬀective.
Three multi-arm RCT's directly tested the relative eﬀectiveness of
incentive strategies when used independently or when combined with
other interventions. One study (French et al., 2017) found that while
giving incentives along with a food assistance program was not eﬀec-
tive relative to a control group that received only food assistance, in-
centives were found to increase weekly fruit purchases when the in-
tervention combined incentives with dietary restrictions on unhealthy
food (sweet baked goods, sugar sweetened beverages, etc.) and food
assistance. Another study found that while an incremental standalone
incentive was ineﬀective relative to a control group that received usual
care, the incremental eﬀect of incentives when added to a computer-
delivered smoking cessation program had an adverse eﬀect on smoking
cessation outcomes (Ondersma et al., 2012). J. T. Kullgren et al. (2014)
tested the relative eﬀectiveness of using incentives alone or combined
with a peer-network based intervention, but neither strategy was found
to be eﬀective.
The limited number of studies and mixed results oﬀers little support
for the hypothesis that the incremental eﬀectiveness of incentives will
be smaller when used as part of a multi-component intervention.
3.2.2. Eﬀectiveness according to population and setting
Five of 6 contrasts (83%) that targeted low-income groups were
found to be eﬀective. This proportion of eﬀective interventions was
slightly lower among interventions targeting the general population in
community settings (14 of 18 contrasts, (78%)) and even lower among
workplace interventions that generally targeted participants of higher
socio-economic status (15 of 27 contrasts, (55%)).
Although there are no RCTs with direct tests of this hypothesis, the
larger proportion of eﬀective interventions targeting low-income
groups compared to interventions in workplace or community settings
is consistent with the hypotheses that incentives may be more likely to
be eﬀective among this population subset.
3.2.3. Eﬀectiveness according to incentive type
Across all studies, the majority (18 of 23 contrasts, (78%)) of cash
based interventions were eﬀective. With one exception, this was also
true among other incentive types: deposit contracts (6 of 8, (75%)),
non-cash incentives (12 of 19, (63%)), and combined incentives (po-
tentially including lotteries) (10 of 12, (83%)). The one exception is
cash-based lotteries in the absence of another form of incentives. For
these, only 1 contrast (1 of 8, (13%) was eﬀective.
Ten contrasts oﬀered non-cash incentives that were more likely to
be perceived as hedonic, and the vast majority were eﬀective (80%). All
interventions that combined incentives with hedonic rewards were ef-
fective (7 contrasts). Among the remaining 9 contrasts that comprised
non-cash incentives that were less likely to be perceived as hedonic, 4
(44%) were found to be eﬀective.
The review identiﬁed three studies with head-to-head comparisons
of diﬀerent incentive types. One study (Patel et al., 2016b) oﬀered a
direct test of the relative eﬀectiveness of a lottery incentive versus a
cash incentive of equivalent value. Neither incentive strategy resulted
in a statistically signiﬁcant eﬀect. No studies oﬀered a direct test of
whether lotteries comprising a low-probability large reward are more
eﬀective than a high-probability small reward, as prospect theory
would predict. Two studies examined the eﬀectiveness of deposit con-
tracts versus other gain-based incentives in a multi-arm RCT (Halpern
et al., 2015; Patel et al., 2016b), but only one ﬁnds results consistent
with theory (Patel et al., 2016b). Limited uptake of deposit contracts
could potentially explain why deposit contracts did not outperform
equivalent cash-based incentives in one study (Halpern et al., 2015),
but did so in the other when deposit contracts were not self-funded but
comprised upfront allocation of funds from the researchers (Patel et al.,
2016b).
No studies directly tested the eﬀectiveness of hedonic rewards
compared to cash. However, one study (Carrera et al., 2018) compared
two non-cash incentives of equivalent value of which one incentive was
cash-like (an Amazon gift-card) while the other could have been per-
ceived as hedonic (pre-selected item chosen from the Amazon website
by the participant before the intervention began). While the item-based
incentive lead to slightly more ﬁtness centre visits than the equivalent
cash-like incentive, the diﬀerence was small and not statistically sig-
niﬁcant. Thus, we have no direct evidence that a hedonic reward would
be more eﬀective than cash.
Although three other studies involved more than one incentive type,
we could not infer the relative eﬀectiveness of one over the other as: (i)
maximum incentive value was not equal across the two incentive arms
(lottery and deposit contracts in Volpp et al. (2008)) or (ii) individuals
had a choice of which arm to join to the independent eﬀect could not be
independently identiﬁed (cash and deposit contracts in Faghri and Li
(2014); cash and lottery in Finkelstein et al. (2017)).
Overall, the current evidence base examining the relative eﬀec-
tiveness of diﬀerent incentive types is limited. Existing literature does
not inform on whether hedonic rewards are more eﬀective than cash
equivalents and provides both limited and mixed evidence on whether
deposit contracts work better than cash equivalents, as theory would
predict. However, the evidence base does suggest that pure cash-based
lotteries are unlikely to be eﬀective, and that among non-cash in-
centives, hedonic rewards appear to be more promising than those less
likely to be perceived as hedonic.
3.2.4. Eﬀectiveness according to frequency of opportunity to earn incentives
Among interventions that provided participants multiple opportu-
nities to earn incentives, more than two-thirds (40 of 56 contrasts,
(71%)) were found to be eﬀective. In particular, the majority of inter-
ventions that oﬀered multiple chances to earn incentives in a week (16
of 22 contrasts, (73%)) were eﬀective. The proportion of interventions
that were found to be eﬀective was lower among contrasts which of-
fered less frequent chances to earn incentives: 7 of 11 contrasts (64%)
that oﬀered chances to earn incentives on a weekly basis, 1 out of 3
(33%) contrasts that do so on a monthly basis, and 6 of 14 (43%)
contrasts less frequently than on a monthly basis or only tied an in-
centive to one goal achievable at the end of the intervention.
Only one weight loss study (Patel et al., 2016a) compared the ef-
fectiveness of two equivalent incentive designs that varied in frequency
of incentive pay-outs: a daily lottery incentive, and a one-time incentive
pay-out in the form of health insurance premium adjustments that
began immediately once a weight loss goal was reached. Neither in-
tervention was found to be eﬀective.
Although no RCTs are available that directly support this claim, the
review suggests that, consistent with theory, interventions with more
frequent opportunities to earn incentives are more likely to be eﬀective.
3.2.5. Eﬀectiveness according to incentive value
Among the quartile of contrasts which oﬀered the smallest in-
centives in terms of maximum incentive pay-out per month, 8 out of 18
(44%) contrasts were found to be eﬀective. In the quartile with the
largest pay-outs 13 out of 18 (72%) were found to be eﬀective.
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Four studies directly tested if larger incentives work better than
smaller ones. Among these, one weight loss study and one ﬁtness centre
attendance study found this hypothesis to be true (Carrera et al., 2018;
Finkelstein et al., 2007), while one other relying on deposit contracts
for weight loss (Jeﬀrey T Kullgren et al., 2016) did not. In one study
using cash rewards for weight loss (Paloyo et al., 2015), larger in-
centives were found to have a greater eﬀect for women and migrants,
but not for the treatment group as a whole.
Our review suggests that larger incentives are more likely to be
eﬀective than smaller ones. Although limited, we also ﬁnd some direct
evidence from head-to-head trials to support the hypothesis that in-
creasing the value of incentives can increase the magnitude of the in-
tervention eﬀect.
3.2.6. Eﬀectiveness according to intervention duration
Contrary to expectations, the proportion of eﬀective interventions
was lower among interventions lasting less than 24 weeks (28 of 42
(67%)) as compared with interventions with a duration of 24 up to 52
weeks (18 of 21 (86%)). However, the proportion of eﬀective inter-
ventions was much lower among the few contrasts that lasted 52 weeks
or longer (3 out of 7 (43%)).
Whereas these results suggest that incentives are likely to be ef-
fective at reducing NCD risk-factors in between 1 and 12 months, evi-
dence for greater than one year is not compelling.
3.3. Evidence for habit formation
Over half of the contrasts (40 out of 70, (57%)) tested for sustained
intervention eﬀects at a time-point after the last incentive could be
earned. Reporting evidence for habit formation was most common
among physical activity interventions (10 of 11 contrasts (91%)) re-
lative to interventions in the domains of ﬁtness session attendance (7 of
12 contrasts (58%)), smoking (13 of 24 contrasts (54%)) and weight
loss (10 of 20 contrasts (50%)). No diet studies tested for sustained
eﬀects. The longest follow-up assessment post-incentive removal varied
signiﬁcantly: ranging from 4 to 100 weeks (median: 13 weeks).
Less than a third of contrasts (11 of 40 (28%)) found evidence for
habit formation at the longest follow-up time point. A slightly greater
proportion of interventions lasting 24 weeks or longer found evidence
for sustained eﬀects (5 of 14 contrasts, (36%)) as compared with shorter
ones (6 of 26 contrasts, (23%)). For interventions incentivising smoking
cessation, weight loss and ﬁtness centre attendance, less than half of
contrasts found evidence for habit formation (smoking cessation: 5 of
13 (38%), weight loss: 3 of 10 (30%), ﬁtness centre attendance (2 of 7
(29%)). The evidence for sustained eﬀects of physical activity inter-
ventions is especially weak; 1 of 10 (10%) contrasts found evidence for
habit formation). Evidence for habit formation is summarised in
Appendix Table 3.
The current evidence base oﬀers no direct evidence for testing the
hypothesis that longer interventions (lasting 24 weeks or greater) are
more likely to result in habit formation than shorter ones. Overall, the
evidence for sustained eﬀects post-incentive removal is weak for all
health domains, and especially so for physical activity.
3.4. Cost and cost-eﬀectiveness of interventions
The average incentive pay-outs per capita were reported or could be
estimated from given information for half of the contrasts (36 of 70,
(51%)). This was most common in the domain of smoking (14 of 24
contrasts, (58%)), followed by weight loss (11 of 20 contrasts, (55%)).
None of the diet studies reported intervention costs. Per capita monthly
incentive pay-outs ranged from - $4 to $245 (median: $44). For two
contrasts, the pay-outs were negative ($2 and $4) due to the use of
deposit contracts which resulted in a net loss of participants’ money.
Only one study reported a cost-eﬀectiveness ﬁnding that could be
used to assess whether the intervention represents good value for
money. Tappin et al. (2015) reported a cost-eﬀectiveness ratio of $698
per QALY gained for smokers in the intervention group who received
shopping vouchers in addition to usual care relative to those who re-
ceived only usual care, and notes that this is cost-eﬀective relative to
established thresholds.
Average incentive pay-outs and eﬀorts to measure cost-eﬀectiveness
are reported in Appendix Table 4. Note that we only report incentive
pay-outs and do not consider labour and other costs associated with
administering the interventions, as most studies did not provide those
values.
3.5. Risk of bias assessment
The heterogeneity in all of the above contrasts clearly demonstrates
the potential for bias when trying to meta-analyse the results. However,
the potential for bias remains even within studies. Although our in-
clusion criteria that limited the review to randomized control trials
minimizes risks for selection bias, many studies reported insuﬃcient
information to assess the integrity of the random sequence generation
(n= 28) and/or concealment of treatment allocation prior to baseline
measurements (n=34). Despite these concerns, only two studies were
considered to be at greater than low risk for selection bias. One study
described a non-random component in the sequence generation process
(Giné et al., 2010) and in the other study allocation to treatment arms
was not concealed prior to enrolment (Carrera et al., 2018).
Additional bias may result if evaluators are aware of the allocation
prior to assessments. Blinding of assessors was reported in only 12
studies and three studies reported that outcome assessors were not
blinded. Regardless, the likelihood of evaluator bias was judged to be
minimal in all studies.
Non-random missing outcome data is another potential source of
bias. When data was missing, reasons for missing outcomes and method
of handling missing data were clearly stated in only 21 studies. Attrition
bias is unclear in the remaining studies as they provided insuﬃcient
information about the reasons for missing outcome data, reasons for
exclusion from analyses or a comparison of the rate of missing re-
sponses by intervention arm.
All but one study (n= 47) pre-speciﬁed the primary outcome and
the method of analysis, and were judged to have a low risk of bias due
to selective outcome reporting. This was unclear for one study
(Donatelle et al., 2000) as the methods of statistical analysis was not
pre-speciﬁed.
Our inclusion criteria also required an objectively measured pri-
mary endpoint. This minimizes self-report bias by participants but does
not rule out other sources of bias. Six studies that use step-counters/
trackers to measure their primary outcome were considered to have
high risk of bias because one cannot distinguish between a true inter-
vention eﬀect and a ‘wear-time’ eﬀect that arises due to the fact that
incentivised participants may simply be wearing their pedometers
longer to earn incentives. Despite being objectively measured, all of the
pedometer based studies are considered to have a risk of bias.
Finally, ten studies used a primary outcome that was a proxy
measure of eﬀectiveness: food purchases or ﬁtness session attendance.
As individuals can meet these objectives without improving their
health, say by attending ﬁtness sessions but not necessarily increasing
their activity levels, these studies provide weak evidence in support of
incentives for improving diet quality or ﬁtness or truly reducing risk
factors for NCDs. A full description of the risk of bias for each study can
be found in Appendix Table 5.
4. Discussion
The aim of this review was to synthesize the evidence of eﬀective-
ness and cost-eﬀectiveness of incentive-based strategies as a tool for
NCD prevention. A systematic review of this nature is important be-
cause prior reviews fall short of answering our primary question, which
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is whether there is truly an evidence base to support the use of in-
centives, large or small, traditional or behavioural, alone or as part of a
multi-component strategy, as a tool for addressing rising rates of NCDs.
4.1. Is there a role for incentives as a tool for NCD prevention?
Our primary ﬁnding is that although the overwhelming majority of
contrasts reviewed (69%) ﬁnd a statistically signiﬁcant intervention
eﬀect, the existing evidence base does not provide a strong case for
incentives as a tool for NCD prevention in any of the included domains.
This results because, upon consideration of potential biases and lim-
itations identiﬁed in the risk of bias assessment, we ﬁnd that 15 of the
70 (21%) contrasts, including all in the food consumption domain, fo-
cused on a proxy measure of eﬀectiveness: food purchases or ﬁtness
session attendance. As individuals can meet these objectives without
improving their health, these studies provide only weak evidence in
support of incentives for NCD prevention. Ten of the remaining 11
studies in the physical activity domain are likely biased because they
are based on pedometers and do not diﬀerentiate an increase in wear
time from an increase in activity. Therefore, these studies also provide
weak evidence. Once these 25 studies are removed, there remains only
one study in the physical activity domain (using sealed accelerometers)
and no studies in the domain of diet and alcohol consumption.
Therefore, the evidence for eﬀectiveness, let alone cost-eﬀectiveness, is
clearly lacking in these domains.
For weight loss, 13 of 20 contrasts (65%) reported a statistically
signiﬁcant intervention eﬀect, whereas for smoking cessation 19 of 24
(79%) contrasts did so. For these domains, the evidence of eﬀectiveness
is more compelling, but the question remains as to whether ﬁnancing
the interventions is a good use of scarce resources. In other words, is
there any evidence of cost-eﬀectiveness? For 7 of 13 contrasts that re-
port statistically signiﬁcant eﬀects in the weight loss domain, average
incentive pay-outs and the diﬀerence in mean weight loss (kg) was
reported. This allowed for the computation of the average cost paid per
kg of weight lost. This ﬁgure ranged from a negative $3/kg lost (i.e.,
cost saving) to $73/kg, with a median of $47/kg lost. For comparison,
average cost per kg lost for WW (formerly Weight Watchers) is $134
(Finkelstein and Kruger, 2014) and the average cost per kg lost for the
weight loss drug Qsymia is $327 (Finkelstein et al., 2015) and both of
these have been shown to be cost-eﬀective based on established
benchmarks for cost-eﬀectiveness. However, in those cases weight loss
was based on 12 month results and on larger weight losses; 3.2 and
6.7 kg compared to a median of 2.9 kg over 12–35 weeks for the in-
centive-based studies. It is unclear whether the weight loss results in the
incentive studies are large enough and/or would be sustained long
enough to be clinically relevant. On the latter point, consistent with
prior reviews (Giles et al., 2014; Mantzari et al., 2015), evidence for
sustained eﬀectiveness post-incentive removal is weak. Only 3 of 10 wt
loss contrasts (33%) which report evidence for habit formation ﬁnd
statistically signiﬁcant evidence of sustained eﬀects. Therefore, we
believe current evidence for the use of incentives in the weight loss
domain is also not compelling as a means to reduce NCDs. This leaves
smoking cessation as the remaining target where incentives may pre-
sent a compelling case.
The existing literature on cost-eﬀectiveness of behavioural inter-
ventions for smoking cessation, such as cognitive behaviour therapy or
telephone counselling, report cost per quit estimates ranging from
$1846/quit to $3397/quit (Ali et al., 2018). For 10 of 19 contrasts in
the smoking cessation domain that allow for generated comparable
estimates, incremental costs per quitter ranged from $274/quit -
$20,503/quit (median: $2212/quit), suggesting that some of the stra-
tegies may be cost-eﬀective. However, less than half of the smoking
cessation interventions which test for sustained eﬀects post-incentive
removal ﬁnd evidence for habit formation (5 of 13 (38%)) which casts
doubt on the cost-eﬀectiveness claim. Therefore, although one study
reports their intervention to be cost-eﬀective (Tappin et al., 2015) on
the whole the evidence base remains weak even for this domain.
4.2. Behavioural economics: hype or help?
In addition to assessing the evidence base for incentives as a tool for
NCD prevention, the review aimed to identify whether one type of in-
centive strategy may work better than others or that incentives work
better for any population subset. The overall heterogeneity in various
aspects of intervention design across studies and the very few studies
(n= 8) that test speciﬁc behavioural economic hypotheses does not
allow for making strong statements about any of the predictions based
on size, type, or frequency of opportunities to earn incentives. However,
the review does oﬀer some suggestions for those looking to design in-
centive-based studies.
The review suggests that multi-pronged incentive strategies may be
most likely to be eﬀective. This includes strategies that target both
participation and outcomes or those that tie incentives to both shorter
and longer term behaviours and outcomes. Eﬀectiveness may be more
likely by oﬀering more frequent opportunities to earn incentives and by
targeting lower income populations. We also found some evidence that
non-cash rewards which are likely to be perceived as hedonic represent
a promising strategy and, consistent with prior reviews, that larger
incentives appear more likely to generate statistically signiﬁcant im-
provements, at least in the weight loss and ﬁtness domains. With one
exception, Ondersma et al. (2012), we also found no evidence of an
undermining eﬀect of incentives, as prior research has suggested
(Gneezy et al., 2011). Yet, although interventions using these incentive
strategies may be most likely to be eﬀective, whether they are cost-
eﬀective for NCD prevention remains unknown.
The review further suggest strategies that appear least compelling.
This includes pure-cash based lotteries, possibly because many parti-
cipants are risk averse and dislike lotteries (Finkelstein et al., 2017),
and deposit contracts. Concerning the latter, whereas interventions
involving deposit-contracts are likely to be eﬀective, potential for scale-
up is limited due to low uptake, even when third party matching is
oﬀered.
Beyond these conjectures, whereas behavioural economic theory
suggests that intervention design aspects have the potential to inﬂuence
intervention eﬀectiveness, results of the review reveal that evidence to
support this claim is both limited and mixed in the context of incentives
for NCD risk-factor reduction.
4.3. Future research and policy implications
Contrary to the implications from many prior studies, literature
reviews, and meta-analyses on the use of traditional and behavioural
economic incentives as a tool to inﬂuence risk factors for NCDs, based
on our review we conclude that the evidence base is not compelling at
this time (Giles et al., 2014; Mantzari et al., 2015; Sutherland et al.,
2008). If one wants to make a stronger case for incentives in NCD
prevention, we would recommend conducting studies that include a
clinical endpoint, are at least 12 months in duration, and that monitor
habit formation beyond the incentive period. Although this has not
always been the case, all future studies focussing on incentives should
conform to best practices for conducting and reporting results of ran-
domized controlled trials, as outlined in the CONSORT statement
(Schulz et al., 2010). Researchers should also systematically report on
the cost-eﬀectiveness of incentives as they would for other health in-
terventions using best practices (Husereau et al., 2013) as a lack of
evidence for cost-eﬀectiveness will make even eﬀective interventions
diﬃcult to justify to policymakers.
In terms of testing behavioural economic theories, future trials
should also adhere to these recommendations and be powered such that
diﬀerences in eﬀect sizes are clinically meaningful. At this time the
evidence from randomized trials is weak that any behavioural strategy
is cost-eﬀective when compared to a simple cash payment for meeting a
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pre-determined goal, such as weight loss or quitting smoking. To make
a case for these strategies, researchers should design trials that allow for
directly testing this hypothesis.
4.4. Strengths and limitations of the review
This is the ﬁrst systematic review to our knowledge that compre-
hensively examines intervention design aspects such as incentive type,
frequency of opportunities to earn incentives, and cost-eﬀectiveness of
incentive-based interventions targeting four key risk-factors for NCDs:
diet, alcohol consumption, physical activity and weight loss.
Consideration of the four key modiﬁable behaviours linked to NCDs
(diet, alcohol consumption, physical inactivity, and smoking) and a
commonly incentivised risk-factor (weight loss) enables us to consider a
broad evidence base that is necessary for understanding the role of
incentives as a tool for NCD prevention. Furthermore, this review
identiﬁes and critically examines the direct evidence for several hy-
potheses motivated by behavioural economic theory which are often
used to design incentive-based interventions, but have not been sys-
tematically assessed for eﬀectiveness in the context of NCD prevention.
These ﬁndings are relevant for policymakers considering the in-
corporation of incentives in large-scale NCD prevention programs.
Limitations of this review include the omission of non-English lan-
guage articles, evidence published before 1995 and evidence from un-
published or grey literature. This may be a potential source of pub-
lication bias. Another limitation was that we did not consider
diﬀerences in methods of estimating intervention eﬀects across studies
or heterogeneity in how the dependent variable was measured both
across and within health domains. It is possible that studies that did not
show eﬀectiveness were underpowered due to small sample sizes,
measurement error, or conservative methods of estimation. Finally, the
review outcomes need to be carefully interpreted for generalizability as
we did not identify any studies in the domain of alcohol consumption
and very few studies in the domain of diet and because results from trial
participants may not represent what would happen in the real world
(Deaton and Cartwright, 2018).
Despite these limitations we believe that our primary conclusion on
the lack of evidence of incentives as a cost-eﬀective strategy for ad-
dressing rising rates of NCDs is justiﬁed. To put this conclusion into
context, if incentives for NCD prevention were being considered for
subvention by NICE or another HTA agency and evaluated as are
medicines, we believe these agencies would not recommend subvention
due to a lack of compelling evidence of long term eﬀectiveness and cost-
eﬀectiveness. For those wishing to make the case, this evidence is sorely
needed.
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